Opioid addiction, if not well diagnosed and treated, can be a significant challenge for optimal pain management even in cancer patients. To date there is no definitive pharmacological standard of care for treating addiction, especially in this setting of patients. We present a clinical case series of three opioid-addicted advanced cancer patients, effectively treated with haloperidol, a well-known first-generation typical antipsychotic.
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series / Parisi, A.; Pensieri, M. V.; Cortellini, A.; D'Orazio, C.; Ficorella, C.; Verna, L.; Porzio, G.. - In: JOURNAL OF ADDICTIVE DISEASES. - ISSN 1055-0887. - 38:2(2020), pp. 229-234. [10.1080/10550887.2020.1742560]
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series
Parisi A.
;D'Orazio C.;
2020-01-01
Abstract
Opioid addiction, if not well diagnosed and treated, can be a significant challenge for optimal pain management even in cancer patients. To date there is no definitive pharmacological standard of care for treating addiction, especially in this setting of patients. We present a clinical case series of three opioid-addicted advanced cancer patients, effectively treated with haloperidol, a well-known first-generation typical antipsychotic.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
